Alvotech (ALVO) Gains from Investment Securities (2023 - 2025)
Alvotech (ALVO) posted Gains from Investment Securities of -$184000.0 for Q4 2025, little changed on a QoQ basis from -$184000.0 in Q4 2024, and little changed year-over-year from -$184000.0 in Q4 2024.
Alvotech (ALVO) Gains from Investment Securities (2023 - 2025) Analysis & Trends
Alvotech's Gains from Investment Securities history runs 3 years deep, the most recent figure standing at -$184000.0 for Q4 2025.
- Quarterly Gains from Investment Securities changed 0.0% year-over-year to -$184000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$142000.0 (changed N/A YoY) and the FY2023 annual result came in at $365000.0, changed N/A from the prior year.
- Gains from Investment Securities was -$184000.0 for Q4 2025 at Alvotech, roughly flat from -$184000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $184000.0 in Q3 2024 and bottomed at -$184000.0 in Q4 2024.
- A 3-year average of -$35500.0 and a median of -$71000.0 in 2023 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2024 — Gains from Investment Securities plunged 538.1% — and 2025, when it changed 0.0%.
- Alvotech's Gains from Investment Securities stood at $42000.0 in 2023, then plunged by 538.1% to -$184000.0 in 2024, then changed by 0.0% to -$184000.0 in 2025.
- Business Quant data shows ALVO's Gains from Investment Securities at -$184000.0 in Q4 2025, -$184000.0 in Q4 2024, and $184000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Alvotech | 907.91 Mn | 907.91 Mn | 5.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -184,000.00 |
| Dec 31, 2025 | -184,000.00 |
| Dec 31, 2024 | -184,000.00 |
| Dec 31, 2024 | -184,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Dec 31, 2023 | 42,000.00 |
| Dec 31, 2023 | 42,000.00 |